News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,002 Results
Type
Article (87760)
Company Profile (824)
Press Release (778402)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233170)
Career Advice (4143)
Deals (39832)
Drug Delivery (144)
Drug Development (91358)
Employer Resources (203)
FDA (18358)
Job Trends (17414)
News (397710)
Policy (39948)
Tag
Academia (3006)
Academic (2)
Accelerated approval (26)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (170)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (304)
Approvals (18466)
Artificial intelligence (579)
Autoimmune disease (134)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (488)
Bladder cancer (150)
Brain cancer (61)
Breast cancer (621)
Cancer (4688)
Cardiovascular disease (409)
Career advice (3565)
Career pathing (40)
CAR-T (290)
CDC (59)
Celiac Disease (1)
Cell therapy (785)
Cervical cancer (36)
Clinical research (76551)
Collaboration (1601)
Company closure (5)
Compensation (1067)
Complete response letters (65)
COVID-19 (2979)
CRISPR (93)
C-suite (740)
Cystic fibrosis (147)
Data (5837)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (494)
Diagnostics (7170)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (272)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (224)
Earnings (99892)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134512)
Executive appointments (1009)
FDA (21220)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1434)
Gene editing (202)
Generative AI (60)
Gene therapy (625)
GLP-1 (1082)
Government (5419)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (276)
Immuno-oncology (41)
Indications (76)
Infectious disease (3249)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (95)
Longevity (14)
Lung cancer (647)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (749)
MASH (165)
Medical device (14970)
Medtech (15009)
Mergers & acquisitions (22875)
Metabolic disorders (1289)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2961)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (61)
Obesity (619)
Opinion (326)
Ovarian cancer (153)
Pain (191)
Pancreatic cancer (200)
Parkinson's disease (272)
Partnered (34)
Patents (470)
Patient recruitment (403)
Peanut (58)
People (66632)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23635)
Phase II (33226)
Phase III (25046)
Pipeline (3886)
Policy (319)
Postmarket research (3554)
Preclinical (10666)
Press Release (72)
Prostate cancer (229)
Psychedelics (52)
Radiopharmaceuticals (287)
Rare diseases (806)
Real estate (7436)
Recruiting (80)
Regulatory (28566)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (235)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4326)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (116)
Vaccines (1107)
Venture capital (79)
Weight loss (433)
Women's health (79)
Worklife (21)
Date
Today (123)
Last 7 days (625)
Last 30 days (2647)
Last 365 days (33320)
2025 (32538)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (326)
Arkansas (14)
Asia (51315)
Australia (9017)
California (10818)
Canada (3170)
China (1054)
Colorado (455)
Connecticut (481)
Delaware (324)
Europe (117970)
Florida (1583)
Georgia (350)
Hawaii (3)
Idaho (68)
Illinois (891)
India (62)
Indiana (521)
Iowa (22)
Japan (376)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1396)
Massachusetts (8013)
Michigan (341)
Minnesota (626)
Mississippi (6)
Missouri (133)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2947)
New Mexico (32)
New York (2891)
North Carolina (1534)
North Dakota (10)
Northern California (5100)
Ohio (330)
Oklahoma (22)
Oregon (52)
Pennsylvania (2190)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4154)
Tennessee (167)
Texas (1701)
United States (39338)
Utah (323)
Vermont (1)
Virginia (271)
Washington D.C. (85)
Washington State (915)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
There are 867,002 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims
Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives a notable drop in COVID-19 sales.
December 16, 2025
·
3 min read
·
Annalee Armstrong
Vaccines
Makary Denies FDA Plans To Levy Black Box Warning on COVID-19 Vaccines
Speaking on
Bloomberg TV
on Monday, FDA Commissioner Marty Makary contradicted recent reporting that suggested the agency was planning to add a black box label—its most serious warning—to COVID-19 vaccines.
December 16, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Sino Biological Wins 2025 Scientist.com’s Supplier Recognition Award
Recognized for Excellence in Drug Discovery Research Services on Global R&D Sourcing Platform in 2025.
December 16, 2025
·
3 min read
Press Releases
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
December 16, 2025
·
5 min read
Press Releases
Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer
December 16, 2025
·
2 min read
Press Releases
Hummingbird Diagnostics Publishes Study on RNA Biomarker Methylation in Liquid Biopsies
December 16, 2025
·
2 min read
Press Releases
Atom Therapeutics Launches Multi-Regional Phase 2 Trial of ABP-745 for Atherosclerotic Cardiovascular Disease (ASCVD)
December 16, 2025
·
4 min read
Press Releases
REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
December 16, 2025
·
15 min read
Press Releases
uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology
December 16, 2025
·
3 min read
Press Releases
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
December 16, 2025
·
7 min read
1 of 86,701
Next
